- Home
- TAVI vs KRRO Comparison
TAVI vs KRRO Comparison
Compare TAVI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAVI
- KRRO
- Stock Information
- Founded
- TAVI 2024
- KRRO 2014
- Country
- TAVI United States
- KRRO United States
- Employees
- TAVI N/A
- KRRO N/A
- Industry
- TAVI
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- TAVI
- KRRO Health Care
- Exchange
- TAVI Nasdaq
- KRRO Nasdaq
- Market Cap
- TAVI 164.0M
- KRRO 147.4M
- IPO Year
- TAVI 2024
- KRRO 2019
- Fundamental
- Price
- TAVI $10.31
- KRRO $31.35
- Analyst Decision
- TAVI
- KRRO Strong Buy
- Analyst Count
- TAVI 0
- KRRO 7
- Target Price
- TAVI N/A
- KRRO $96.71
- AVG Volume (30 Days)
- TAVI 2.1K
- KRRO 235.6K
- Earning Date
- TAVI 01-01-0001
- KRRO 11-11-2025
- Dividend Yield
- TAVI N/A
- KRRO N/A
- EPS Growth
- TAVI N/A
- KRRO N/A
- EPS
- TAVI 5.42
- KRRO N/A
- Revenue
- TAVI N/A
- KRRO $6,281,000.00
- Revenue This Year
- TAVI N/A
- KRRO $97.27
- Revenue Next Year
- TAVI N/A
- KRRO N/A
- P/E Ratio
- TAVI $1.90
- KRRO N/A
- Revenue Growth
- TAVI N/A
- KRRO N/A
- 52 Week Low
- TAVI $9.89
- KRRO $10.29
- 52 Week High
- TAVI $10.72
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- TAVI N/A
- KRRO 65.78
- Support Level
- TAVI N/A
- KRRO $20.20
- Resistance Level
- TAVI N/A
- KRRO $37.03
- Average True Range (ATR)
- TAVI 0.00
- KRRO 3.61
- MACD
- TAVI 0.00
- KRRO 0.48
- Stochastic Oscillator
- TAVI 0.00
- KRRO 67.41
About TAVI Tavia Acquisition Corp. Ordinary Shares
Tavia Acquisition Corp is a blank check company.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.